Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stephen Deitsch is Director at Aclarion. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 12, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Stephen Deitsch reported holding 20,000 shares of Aclarion (ACON), worth about $31K at the last close of $2 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Aclarion ACON | 20,000 | 20K direct | $2 | $31K | Jun 11, 2026 |
Is this Stephen Deitsch’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Stephen Deitsch bought shares on the open market in 2017, and has not bought since 2017.
Stephen Deitsch reported 1 open-market purchase and 0 sales since 2017; purchases in 2017.
| Year | Bought | Sold |
|---|---|---|
| 2017 | $20K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
AclarionACON
Jun 11, 202620Kdisclosed Jun 12
DetailsOfficial recordOn the latest SEC Form 4, dated Jun 11, 2026, Stephen Deitsch reported holding 20,000 shares of Aclarion (ACON). At the last close of $2 on Nov 13, 2026, that is about $31K. This is the stake disclosed in filings, not a net worth.
Stephen Deitsch bought shares on the open market in 2017, and has not bought since 2017.
In SEC filings since 2017: the latest open-market purchase is from 2017; no open-market sale is on record.
Option Care Health (OPCH), from 2017 to 2017: 1 purchase and 0 sales.
Stephen Deitsch reported 1 open-market purchase and 0 sales here, 2017.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
